Since 1 July 2024, Sponsors of clinical trials with medicinal products, medical devices and novel therapies that are not financed by commercial third-party funding may apply for a fee reduction. Further information can be found on the Swissmedic website:
The Federal Council approved the amendments to the ordinances relating to the Human Research Act (HRA) and adopted them on 7 June 2024. The amendments strengthen the protection of persons participating in research and, where possible, improve the regulatory framework for researchers. The amended ordinances enter into force on 1 November 2024, with the exception of the provisions on transparency, which enter into force on 1 March 2025.
Further information can be found on the kofam website.
On 7 June 2024, the Federal Council instructed the Federal Department of Home Affairs (FDHA) to revise the Human Research Act (HRA) and submit a draft act to it by the end of 2026. Further information can be found on the page «The regulation of human research in Switzerland».